Literature DB >> 8144873

IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study.

E A Carpenter1, J Ruby, I A Ramshaw.   

Abstract

The production of cytokines by virus immune spleen cells after in vitro restimulation was investigated. Vaccinia virus-primed spleen cells from CBA/H mice were stimulated in vitro with virus-infected UV-irradiated syngeneic cells. Both CD4+ and CD8+ T cell populations proliferated after restimulation. TNF, IL-6, and IFN-gamma were detected within 12 h of restimulation with maximal levels reached by 24 h. Adherent cells were major producers of IL-6 and TNF, whereas IFN-gamma production was dependent on CD4+ T cells and adherent cells. The IFN-gamma response was Ag specific, whereas the production of TNF and IL-6 was not. Stimulation with vaccinia virus constructs encoding IFN-gamma or TNF altered the levels of cytokines produced, in that IFN-gamma expression by stimulator cells led to increased IFN-gamma production, whereas TNF expression by stimulator cells augmented both TNF and IFN-gamma production by responder cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144873

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

Authors:  K H Leong; A J Ramsay; D B Boyle; I A Ramshaw
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

2.  A mechanism for the inhibition of fever by a virus.

Authors:  A Alcamí; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

3.  The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.

Authors:  Joanna L Shisler; Xiao-Lu Jin
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.

Authors:  H Ghiasi; S L Wechsler; R Kaiwar; A B Nesburn; F M Hofman
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

5.  A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation.

Authors:  Zhijun Liu; Himani Nailwal; Jonah Rector; Masmudur M Rahman; Richard Sam; Grant McFadden; Francis Ka-Ming Chan
Journal:  Immunity       Date:  2021-01-13       Impact factor: 31.745

Review 6.  Mucosal adjuvanticity of immunostimulatory DNA sequences.

Authors:  A A Horner; N Cinman; A Ronaghy; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

7.  Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunity.

Authors:  Bastiaan A Blok; Kristoffer J Jensen; Peter Aaby; Anders Fomsgaard; Reinout van Crevel; Christine S Benn; Mihai G Netea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-05       Impact factor: 5.103

8.  Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.

Authors:  Jessamine E Hazlewood; Troy Dumenil; Thuy T Le; Andrii Slonchak; Stephen H Kazakoff; Ann-Marie Patch; Lesley-Ann Gray; Paul M Howley; Liang Liu; John D Hayball; Kexin Yan; Daniel J Rawle; Natalie A Prow; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2021-01-13       Impact factor: 6.823

9.  Vaccinia virus-regulated acute phase cytokine production in human fibroblasts, U937 cells and endothelium.

Authors:  H Rokita; T Kupiec; K Guzik; A Koj
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

Review 10.  Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development.

Authors:  Yongjun Sui; Jay A Berzofsky
Journal:  Front Immunol       Date:  2020-02-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.